title: Extensive oral herpes simplex virus type 1 infection in a haematopoietic stem cell transplant recipient not responding to aciclovir.
authors.affiliation: Department of Virology, Health Protection Agency Microbiology Services, Newcastle, UK. samuel.moses@nhs.net
authors.forename: S E
authors.initials: SE
authors.lastname: Moses
authors.forename: W
authors.initials: W
authors.lastname: Osborne
authors.forename: M
authors.initials: M
authors.lastname: Valappil
authors.forename: M
authors.initials: M
authors.lastname: Collin
authors.forename: D
authors.initials: D
authors.lastname: Lee
authors.forename: S
authors.initials: S
authors.lastname: Waugh
authors.forename: G
authors.initials: G
authors.lastname: Jackson
authors.forename: C M
authors.initials: CM
authors.lastname: Parry
authors.forename: B
authors.initials: B
authors.lastname: Crowley
mesh_terms: D000212:Acyclovir / Q000494:pharmacology / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D024882:Drug Resistance, Viral / Q000187:drug effects; D017245:Foscarnet / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006561:Herpes Simplex / Q000188:drug therapy* / Q000209:etiology / Q000821:virology; D018259:Herpesvirus 1, Human; D006689:Hodgkin Disease / Q000150:complications / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009055:Mouth / Q000821:virology*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D017245:Foscarnet; D000212:Acyclovir